{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T13:50:35Z","timestamp":1775742635493,"version":"3.50.1"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Various bone resorption markers in humans are useful for supporting the diagnosis of malignant skeletal pathology, with certain bone resorption markers appearing to be more discriminatory for detecting cancer-induced osteolysis than others. Canine osteosarcoma (OSA) is characterized by focal bone destruction, but a systematic investigation for determining which bone resorption marker best supports the diagnosis of OSA in dogs has not been reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis<\/jats:title>\n                    <jats:p>Dogs with OSA will have increased concentrations of bone resorption markers compared with healthy dogs and dogs with orthopedic disorders. Differences will exist among various bone resorption markers for their ability to support the diagnosis of malignant osteolysis in dogs with OSA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Single time point, cross-sectional, cohort study including dogs with OSA (n = 20) or orthopedic disorders (n = 20) and healthy dogs (n = 22).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Basal concentrations of urine and serum N-telopeptide (NTx), urine and serum C-telopeptide (CTx), and urine deoxypyridinoline (DPD) were compared among all 3 groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared with healthy dogs and dogs with orthopedic disorders, urine NTx, serum NTx, and serum CTx concentrations were significantly increased in dogs with OSA. For urine NTx and serum NTx, the calculated lower and upper 95% confidence limits in dogs with OSA did not overlap with dogs diagnosed with orthopedic disorders or healthy dogs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and clinical importance<\/jats:title>\n                    <jats:p>Of the markers evaluated in this study, urine NTx and serum NTx appear to be the most discriminatory resorption markers supporting the diagnosis of focal malignant osteolysis in dogs with OSA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1939-1676.2008.0134.x","type":"journal-article","created":{"date-parts":[[2009,1,22]],"date-time":"2009-01-22T11:12:46Z","timestamp":1232622766000},"page":"1008-1013","source":"Crossref","is-referenced-by-count":11,"title":["A Comparison of Five Different Bone Resorption Markers in Osteosarcoma-Bearing Dogs, Normal Dogs, and Dogs with Orthopedic Diseases"],"prefix":"10.1093","volume":"22","author":[{"given":"P.W.","family":"Lucas","sequence":"first","affiliation":[{"name":"University of Illinois at Urbana-Champaign Department of Veterinary Clinical Medicine, , Urbana, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.M.","family":"Fan","sequence":"additional","affiliation":[{"name":"University of Illinois at Urbana-Champaign Department of Veterinary Clinical Medicine, , Urbana, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.D.","family":"Garrett","sequence":"additional","affiliation":[{"name":"University of Illinois at Urbana-Champaign Department of Veterinary Clinical Medicine, , Urbana, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.J.","family":"Griffon","sequence":"additional","affiliation":[{"name":"University of Illinois at Urbana-Champaign Department of Veterinary Clinical Medicine, , Urbana, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Wypij","sequence":"additional","affiliation":[{"name":"University of Illinois at Urbana-Champaign Department of Veterinary Clinical Medicine, , Urbana, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,7,1]]},"reference":[{"key":"2026020304230469200_b1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/mpo.10334","article-title":"Biology of the basic multicellular unit and the pathophysiology of osteoporosis","volume":"41","author":"Jilka","year":"2003","journal-title":"Med Pediatr Oncol"},{"key":"2026020304230469200_b2","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1002\/1097-0142(20000615)88:12+<2919::AID-CNCR7>3.0.CO;2-Z","article-title":"Biochemical markers and skeletal metastases","volume":"88","author":"Demers","year":"2000","journal-title":"Cancer"},{"key":"2026020304230469200_b3","first-page":"13","article-title":"Role of biochemical markers of bone remodeling in clinical practice","volume":"30","author":"Camozzi","year":"2007","journal-title":"J Endocrinol Invest"},{"key":"2026020304230469200_b4","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00228-006-0174-3","article-title":"An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice","volume":"62","author":"Leeming","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"key":"2026020304230469200_b5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0889-8529(02)00077-4","article-title":"Biochemical markers of bone remodeling","volume":"32","author":"Seibel","year":"2003","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2026020304230469200_b6","first-page":"S138","article-title":"Biochemical markers and skeletal metastases","volume":"2003","author":"Demers","journal-title":"Clin Orthop Relat Res"},{"key":"2026020304230469200_b7","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2460\/ajvr.2005.66.1487","article-title":"Effects of zoledronate on markers of bone metabolism and subchondral bone mineral density in dogs with experimentally induced cruciate-deficient osteoarthritis","volume":"66","author":"Agnello","year":"2005","journal-title":"Am J Vet Res"},{"key":"2026020304230469200_b8","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1038\/sj.bjc.6601437","article-title":"Bone resorption predicts for skeletal complications in metastatic bone disease","volume":"89","author":"Brown","year":"2003","journal-title":"Br J Cancer"},{"key":"2026020304230469200_b9","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1939-1676.2007.tb02986.x","article-title":"Single-agent pamidronate for palliative therapy of canine appendicular osteosarcoma bone pain","volume":"21","author":"Fan","year":"2007","journal-title":"J Vet Intern Med"},{"key":"2026020304230469200_b10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1053\/ctrv.2000.0213","article-title":"Markers of bone turnover in prostate cancer","volume":"27","author":"Garnero","year":"2001","journal-title":"Cancer Treat Rev"},{"key":"2026020304230469200_b11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0009-8981(00)00323-5","article-title":"Comparison of urinary markers for bone resorption in multiple myeloma","volume":"300","author":"Houze","year":"2000","journal-title":"Clin Chim Acta"},{"key":"2026020304230469200_b12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1939-1676.2006.tb02865.x","article-title":"Urine N-telopeptide excretion in dogs with appendicular osteosarcoma","volume":"20","author":"Lacoste","year":"2006","journal-title":"J Vet Intern Med"},{"issue":"4","key":"2026020304230469200_b13","doi-asserted-by":"crossref","first-page":"P22","DOI":"10.1359\/jbmr.06s204","article-title":"Biochemical assessment of Paget's disease of bone","volume":"21","author":"Shankar","year":"2006","journal-title":"J Bone Miner Res"},{"key":"2026020304230469200_b14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00776-007-1113-6","article-title":"Change of cross-linked telopeptide of type I collagen (ICTP) and other bone resorption markers in patients with bone fragility fractures","volume":"12","author":"Takahara","year":"2007","journal-title":"J Orthop Sci"},{"key":"2026020304230469200_b15","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1158\/1078-0432.CCR-06-0269","article-title":"Markers of bone metabolism and survival in men with hormone-refractory metastatic prostate cancer","volume":"12","author":"Cook","year":"2006","journal-title":"Clin Cancer Res"},{"key":"2026020304230469200_b16","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1200\/JCO.2002.20.3.850","article-title":"Prospective evaluation of the peptide-bound collagen type I cross-links N-telopeptide and C-telopeptide in predicting bone metastases status","volume":"20","author":"Costa","year":"2002","journal-title":"J Clin Oncol"},{"key":"2026020304230469200_b17","first-page":"24","article-title":"Clinical usefulness of bisphosphonates in oncology","volume":"22","author":"Veri","year":"2007","journal-title":"Treatment of bone metastases, antitumoral activity and effect on bone resorption markers"},{"key":"2026020304230469200_b18","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/S0959-8049(98)00277-9","article-title":"Markers of bone resorption in patients treated with pamidronate","volume":"34","author":"Lipton","year":"1998","journal-title":"Eur J Cancer"},{"key":"2026020304230469200_b19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1939-1676.2005.tb02661.x","article-title":"Evaluation of intravenous pamidronate administration in 33 cancer-bearing dogs with primary or secondary bone involvement","volume":"19","author":"Fan","year":"2005","journal-title":"J Vet Intern Med"},{"key":"2026020304230469200_b20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1354\/vp.42-2-161","article-title":"Use of alkaline phosphatase staining to differentiate canine osteosarcoma from other vimentin-positive tumors","volume":"42","author":"Barger","year":"2005","journal-title":"Vet Pathol"},{"key":"2026020304230469200_b21","first-page":"145","article-title":"Diagnosing appendicular osteosarcoma with ultrasound-guided fine-needle aspiration","volume":"48","author":"Britt","year":"2007","journal-title":"36 cases"},{"key":"2026020304230469200_b22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/rvsc.2000.0397","article-title":"Urinary markers of type I collagen degradation in the dog","volume":"69","author":"Allen","year":"2000","journal-title":"Res Vet Sci"},{"key":"2026020304230469200_b23","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s00223-001-1026-x","article-title":"Biological variability in serum and urinary indices of bone formation and resorption in dogs","volume":"70","author":"Ladlow","year":"2002","journal-title":"Calcif Tissue Int"},{"key":"2026020304230469200_b24","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2460\/ajvr.1998.59.03.250","article-title":"Serum markers of bone metabolism in dogs","volume":"59","author":"Allen","year":"1998","journal-title":"Am J Vet Res"},{"key":"2026020304230469200_b25","first-page":"1002","article-title":"Prognostic importance of alkaline phosphatase activity in serum from dogs with appendicular osteosarcoma","volume":"213","author":"Ehrhart","year":"1998","journal-title":"75 cases (1990\u20131996)"},{"key":"2026020304230469200_b26","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1939-1676.2000.tb02281.x","article-title":"Prognostic significance of serum alkaline phosphatase activity in canine appendicular osteosarcoma","volume":"14","author":"Garzotto","year":"2000","journal-title":"J Vet Intern Med"},{"key":"2026020304230469200_b27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00223-002-1046-1","article-title":"Urinary excretion of pyridinium cross-links and serum osteocalcin levels in patients with primary high-grade osteosarcoma","volume":"73","author":"Ferrari","year":"2003","journal-title":"Calcif Tissue Int"},{"key":"2026020304230469200_b28","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1034\/j.1600-0609.2000.065005331.x","article-title":"Effect of pamidronate administration on markers of bone turnover and disease activity in multiple myeloma","volume":"65","author":"Terpos","year":"2000","journal-title":"Eur J Haematol"},{"key":"2026020304230469200_b29","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1507\/endocrj.52.667","article-title":"Early changes in biochemical markers of bone turnover predict bone mineral density response to antiresorptive therapy in Korean postmenopausal women with osteoporosis","volume":"52","author":"Kim","year":"2005","journal-title":"Endocr J"},{"key":"2026020304230469200_b30","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S8756-3282(98)00183-5","article-title":"Biochemical markers can predict the response in bone mass during alendronate treatment in early postmenopausal women. Alendronate Osteoporosis Prevention Study Group","volume":"24","author":"Ravn","year":"1999","journal-title":"Bone"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1939-1676.2008.0134.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/22\/4\/1008\/66674816\/j.1939-1676.2008.0134.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/22\/4\/1008\/66674816\/j.1939-1676.2008.0134.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:23:18Z","timestamp":1770110598000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/22\/4\/1008\/8450113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,1]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,7,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1939-1676.2008.0134.x","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2008,7]]},"published":{"date-parts":[[2008,7,1]]}}}